WRITTEN BY
As the year swiftly draws to a close, it's time to wrap it up and focus on enhancing the bonds of togetherness with family, friends, and loved ones.
Reflecting on the past year, AstraZeneca BioVentureHub has experienced a fantastic and intense journey filled with achievements, changes, and joy, all thanks to the wonderful people in our ecosystem, partnerships, community, and colleagues at AstraZeneca.
We're excited to tackle our mutual challenges ahead.
The recent Nobel Prize speeches highlighted important topics such as health, climate, and sustainability, emphasizing the need for economic and political bodies to drive health equity and inclusion. These discussions addressed both threats and solutions, with AI and technological advancements playing dual roles.
With the upgraded National Life Science Strategy, the AI Commission report, and a new proposal for the Government's Research & Development Policy, we aim to contribute to position Sweden as a leading life science country. With these substantial thoughts in mind, this year’s AZ Exchange meeting gathered 150 key Life Science executives to discuss the updated national Life Science Strategy. The discussions where centred on defining the meaning of a leading life science nation in the context of industry.
In light of the importance of new technology, BioVentureHub has during 2024 welcomed three new companies representing the areas of Quantum Computing, AI and Organ on a Chip technology. We are enthusiastic about the fact that three promising international companies choose to join BioVentureHub in order to advance these technologies even further. Read more in this news post.
Exploring the Journey of Innovation: Stories from BioVentureHub
This year, we have been working on a series of articles describing the experiences of companies present within the BioVentureHub, what they have encountered during their time here, the challenges and opportunities they’ve experienced, and what has helped them develop and grow as a company.
The stories focus on areas such as AstraZeneca Infrastructure and Expertise, the role in catalyzing collaboration, and our way of Cultivating a “dare to share” culture for life science innovation. These are perfect Christmas reads if you are curious about our unique innovation platform.
Stay tuned by signing up for our newsletter to get a personal heads-up, Sign up here.
We would like to thank all the great people we meet in the community, our ecosystem, our colleagues at AstraZeneca, and all the ones that have helped us with our events and activities throughout the year. We especially would like to thank our friends at MyGreenLab who have helped us putting sustainability at the core of everything we do.
Finally, we want to thank all experts and partners that contributed to making our series of seminars on financing and investor relations a success.
We wish you some truly nice days off. Hopefully, you can recharge, rest, and enjoy good company, a book or two, or whatever energizes you.
Merry Christmas and a Happy New Year from the BioVentureHub team.
The BioVentureHub Team; Pernilla Isberg, Ulrika Edvardsson, Robert Roth, Emma Wiesel and Robert Börjes.
Follow AstraZeneca BioVentureHub on Linkedin: Click here.
Sign up for the BioVentureHub Newsletter: Sign up here.